Effect of aspirin for prevention of preeclampsia in women with abnormalultrasonic findings in uterine artery

Phase 3

• Conditions: Condition 1: Preeclampsia. Condition 2: Preeclampsia.; Gestational [pregnancy-induced] hypertension without significant proteinuria; Gestational [pregnancy-induced] hypertension with significant proteinuria

• Registration Number: IRCT201505103025N5
• Lead Sponsor: Vice-Chancellor for Research of Qazvin University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

pregnant women; singletone; gestational age 11-15 weeks; abnormal finding in uterine artery doppler sonography
exclusion criteria: underlying medical condition; history of asthma; allergic to aspirin; termination of pregnancy before 20 weeks of pregnancy

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Preeclampsia. Timepoint: Measurement of Blood pressure every two weeks until 28 w then every week until termination of pregnancy. Method of measurement: Barometer, mmHg.

Secondary Outcome Measures

Name	Time	Method
Intrauterine Growth Retardation. Timepoint: Every two weeks until 28 w then every week until termination of pregnancy. Method of measurement: Doppler Ultrasound If fetal growth retardation is suspected.;1 and 5 min apgar. Timepoint: 1 and 5 min after birth. Method of measurement: Standard apgar score.;Neonatal Weight. Timepoint: After Birth. Method of measurement: Digital Scale(gram).